Please use this identifier to cite or link to this item:
|Title:||The Role of CT Scanning in Multidimensional Phenotyping of COPD|
Raj, J. Vimal
Vara, Dhiraj D.
Entwisle, James J.
Pavord, Ian D.
Brightling, Christopher E.
|Publisher:||American College of Chest Physicians (ACCP)|
|Citation:||Chest, 2011, 140 (3), pp. 634-642|
|Abstract:||Background: COPD is a heterogeneous disease characterized by airflow obstruction and diagnosed by lung function. CT imaging is emerging as an important, noninvasive tool in phenotyping COPD. However, the use of CT imaging in defining the disease heterogeneity above lung function is not fully known. Methods: Seventy-five patients with COPD (58 men, 17 women) were studied with CT imaging and with measures of airway inflammation. Airway physiology and health status were also determined. Results: The presence of emphysema (EM), bronchiectasis (BE), and bronchial wall thickening (BWT) was found in 67%, 27%, and 27% of subjects, respectively. The presence of EM was associated with lower lung function (mean difference % FEV[subscript 1] , -20%; 95% CI, -28 to -11; P<.001). There was no difference in airway inflammation, exacerbation frequency, or bacterial load in patients with EM alone or with BE and/or BWT±EM. The diffusing capacity of the lung for carbon monoxide/alveolar volume ratio was the most sensitive and specific parameter in identifying EM (area under the receiver operator characteristic curve, 0.87; 95% CI, 0.79-0.96). Physiologic cluster analysis identified three clusters, two of which were EM predominant and the third characterized by a heterogeneous combination of EM and BE. Conclusions: The application of CT imaging can be useful as a tool in the multidimensional approach to phenotyping patients with COPD.|
|Rights:||Copyright © 2011 American College of Chest Physicians. This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Information for commercial entities is available online (http://www.chestpubs.org/site/misc/reprints.xhtml).|
|Appears in Collections:||Published Articles, Dept. of Infection, Immunity and Inflammation|
Files in This Item:
|103007.pdf||Published (publisher PDF)||618.17 kB||Adobe PDF||View/Open|
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.